Protein Folding Activity of Ribosomal RNA Is a Selective Target of Two Unrelated Antiprion Drugs

Déborah Tribouillard-Tanvier, Suzana Dos Reis, Fabienne Gug et al. · 2008

Read Protein Folding Activity of Ribosomal RNA Is a Selective Target of Two Unrelated Antiprion Drugs by Déborah Tribouillard-Tanvier, Suzana Dos Reis, Fabienne Gug et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002174.txt.

Description

Déborah Tribouillard-Tanvier, Suzana Dos Reis, Fabienne Gug, and co-authors tested how two anti-prion drugs work, in a 2008 PLOS ONE paper. Prions are faulty proteins that cause fatal brain diseases. Two drugs with no structural likeness, 6AP and guanabenz, were found through a yeast test to block prions. Both also work against mammal prions in cells.

The team reports that the folding help given by ribosomal RNA is the shared target of both drugs. Ribosomal RNA helps assemble the cell's protein factories and can aid protein folding. A single shared target for two unlike drugs is a strong lead for designing better anti-prion treatments.

Catalog record

CREATORDéborah Tribouillard-Tanvier, Suzana Dos Reis, Fabienne Gug et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE66 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002174

Browse the full library · About the Tower of Babel